ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects

NCT04307082 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Fungal Infection

Interventions

DRUG: [14C]-Ibrexafungerp

Sponsor

Scynexis, Inc.

Collaborators

[object Object]